According to a new review, chronic asthma patients can have a new treatment option allowing them to manage their ailment in an effective manner with a single prescribed inhaler that contains two medicines.

In the recent past, researchers have been examining the usage of both beta2-agonist (formoterol) and a low-dose corticosteroid (budesonide) in a single inhaler and this review evaluated the new inhaler’s effectiveness.

From News-Medical.Net:

“Encouraging people to use their preventive medication is important, as it is often the case that people with asthma default on their inhaled corticosteroids,” said lead reviewer Christopher Cates, M.D., at the Community Health Sciences of St. George’s at the University of London. “This is partly because inhaled steroids do not make an immediate difference to asthma symptoms.”

In most studies, participants had treatment with a single inhaler - one inhalation of 80/4.5 milligrams of budesonide/formoterol twice daily, and as needed. Patients in the control groups used their prescribed inhaled corticosteroid with a separate reliever inhaler. Cates and his colleague evaluated three studies that included more than 4,200 adults and adolescents with chronic asthma. One study also included 224 children.

The Cochrane reviewers found no significant reduction in the number of asthma exacerbations that required hospitalization among the patients who used single inhaler therapy.

Carlos Camargo, M.D., an associate professor of medicine at Harvard Medical School, remarked that the single-inhaler therapy is a new approach to chronic asthma treatment that works but requires further study.

Bookmark It

Hide Sites

Tags: budesonide, chronic asthma, corticosteroid, inhaler, steroids

Posted in Steroid Cycles, Steroids and Anabolic Steroids, buy steroids, steroid nation